LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Cash from Restructuring (2024)

Updated

LENZ Therapeutics (LENZ) posted Cash from Restructuring of -$4.77 million for Q2 2024.

Analysis

LENZ Therapeutics (LENZ) Cash from Restructuring (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -2.42 Mn
Jun 30, 2024 -4.77 Mn
Mar 31, 2024 4.82 Mn
API Access

LENZ Therapeutics Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=LENZ&period=max&api_key=YOUR_API_KEY